| __timestamp | Alpine Immune Sciences, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 22223073 |
| Thursday, January 1, 2015 | 16054000 | 6966842 |
| Friday, January 1, 2016 | 23316000 | 9000499 |
| Sunday, January 1, 2017 | 10626000 | 13741186 |
| Monday, January 1, 2018 | 28970000 | 19040000 |
| Tuesday, January 1, 2019 | 35847000 | 23559000 |
| Wednesday, January 1, 2020 | 27185000 | 31931000 |
| Friday, January 1, 2021 | 58742000 | 44981000 |
| Saturday, January 1, 2022 | 70243000 | 54234000 |
| Sunday, January 1, 2023 | 80904000 | 63806000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc. have demonstrated varying levels of investment in R&D, reflecting their strategic priorities.
From 2014 to 2023, Alpine Immune Sciences, Inc. has consistently increased its R&D spending, culminating in a 563% rise by 2023. This upward trend underscores their dedication to pioneering new therapies. In contrast, Viking Therapeutics, Inc. has shown a more moderate increase of 187% over the same period, indicating a steady yet cautious approach to innovation.
Alpine's aggressive R&D investment suggests a focus on rapid growth and market leadership, while Viking's strategy may prioritize sustainable development and risk management. As these companies continue to evolve, their R&D spending will remain a critical factor in their success.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.